Furthermore, IL-38 released from apoptotic cells inhibited IL-6 production by attenuating the JNK/AP-1 pathway, thereby modulating macrophage responses (12), which could influence NSCLC development. Here, IL6 is linked to non-small cell lung carcinoma.